MAVENS BIOTECH LTD. - Statement of deviation or variation for the quarter ended December 31, 2016
12 Jan 2017
Mavens Biotech Ltd has submitted to BSE a copy of the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended December 31, 2016.
Source:
BSE India